Jenny Link, MD
Dermatology · Rochester, MNNPI 1124552690
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 32 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 12 manufacturers reported payments, led by Bristol Myers Squibb at 24.7% of the total. Reporting peaked in 2021 at $463 and has fallen 71.9% since, to $130 in 2024.
Across 32 payments — averaging $31.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bristol Myers Squibb$250
- AbbVie$180
- Johnson & Johnson$148
- Pfizer$145
- Amgen$107
- Lilly USA, LLC$46
- plus $138 from 6 others
What the payments were for
- Food & beverage$1,014100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bristol Myers Squibb | 2 | $250 |
| AbbVie | 6 | $180 |
| Johnson & Johnson | 2 | $148 |
| Pfizer | 11 | $145 |
| Amgen | 1 | $107 |
| Lilly USA, LLC | 2 | $46 |
| Sanofi | 2 | $34 |
| UCB, Inc. | 2 | $34 |
| Kyowa Kirin, Inc. | 1 | $23 |
| Regeneron Healthcare Solutions, Inc. | 1 | $20 |
| Novartis | 1 | $15 |
| Sun Pharmaceutical Industries Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,014 in reported general payments places this provider in the 75th percentile of 273 dermatology providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 20 | $75,544 |
| Tacrolimus | 29 | $5,970 |
| Clobetasol Propionate | 65 | $3,869 |
| Fluocinonide | 17 | $1,117 |
| Tretinoin | 13 | $1,115 |
| Doxycycline Monohydrate | 29 | $1,059 |
| Ketoconazole | 57 | $1,020 |
| Mycophenolate Mofetil | 16 | $971 |
| Triamcinolone Acetonide | 71 | $705 |
| Hydroxychloroquine Sulfate | 26 | $495 |
| Lidocaine Hcl ViscousLidocaine Hcl | 14 | $469 |
| Clindamycin Phosphate | 12 | $319 |
| Doxepin Hcl | 14 | $318 |
| Hydrocortisone | 52 | $300 |
| Doxycycline Hyclate | 12 | $261 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Rochester
- Afsaneh AlaviRochester$71K
- Saranya WylesRochester$25K
- Nessa Aghazadeh MohandesiRochester$11K
- Alina BridgesRochester$11K
- Megha TollefsonRochester$8K
- Julia LehmanRochester$8K
- Michael WangRochester$7K
- Michael CamilleriRochester$5K
- Jennifer MartinRochester$3K
- Julio Sartori-ValinottiRochester$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.